ATE528305T1 - Verfahren zur herstellung oder reinigung von olmesartan-medoxomil oder von olmesartan- medoxomil-hydrohalid-salz - Google Patents
Verfahren zur herstellung oder reinigung von olmesartan-medoxomil oder von olmesartan- medoxomil-hydrohalid-salzInfo
- Publication number
- ATE528305T1 ATE528305T1 AT08786993T AT08786993T ATE528305T1 AT E528305 T1 ATE528305 T1 AT E528305T1 AT 08786993 T AT08786993 T AT 08786993T AT 08786993 T AT08786993 T AT 08786993T AT E528305 T1 ATE528305 T1 AT E528305T1
- Authority
- AT
- Austria
- Prior art keywords
- olmesartan medoxomil
- purification
- production
- hydrohalide salt
- olmesartan
- Prior art date
Links
- 239000002051 C09CA08 - Olmesartan medoxomil Substances 0.000 title abstract 4
- UQGKUQLKSCSZGY-UHFFFAOYSA-N Olmesartan medoxomil Chemical compound C=1C=C(C=2C(=CC=CC=2)C2=NNN=N2)C=CC=1CN1C(CCC)=NC(C(C)(C)O)=C1C(=O)OCC=1OC(=O)OC=1C UQGKUQLKSCSZGY-UHFFFAOYSA-N 0.000 title abstract 4
- 229960001199 olmesartan medoxomil Drugs 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 238000000746 purification Methods 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07114000A EP2022790A1 (de) | 2007-08-08 | 2007-08-08 | Verfahren zur Herstellung oder Reinigung von Olmesartan-Medoxomil |
| EP07114004A EP2036904A1 (de) | 2007-08-08 | 2007-08-08 | Verfahren zur Herstellung von Olmesartan-Medoxomil |
| PCT/EP2008/060396 WO2009019303A2 (en) | 2007-08-08 | 2008-08-07 | A process for the preparation or purification of olmesartan medoxomil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE528305T1 true ATE528305T1 (de) | 2011-10-15 |
Family
ID=39789494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08786993T ATE528305T1 (de) | 2007-08-08 | 2008-08-07 | Verfahren zur herstellung oder reinigung von olmesartan-medoxomil oder von olmesartan- medoxomil-hydrohalid-salz |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8592474B2 (de) |
| EP (2) | EP2176253B1 (de) |
| JP (2) | JP5685082B2 (de) |
| CN (2) | CN101778843A (de) |
| AT (1) | ATE528305T1 (de) |
| BR (2) | BRPI0815134A2 (de) |
| CA (2) | CA2707334C (de) |
| SI (1) | SI2176253T1 (de) |
| WO (2) | WO2009019303A2 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5685082B2 (ja) * | 2007-08-08 | 2015-03-18 | レツク・フアーマシユーテイカルズ・デー・デー | オルメサルタンメドキソミルの調製または精製の方法 |
| EP2298763B1 (de) | 2008-06-09 | 2015-03-25 | Daiichi Sankyo Company, Limited | Verfahren zur herstellung einer 1-biphenylmethylimidazolverbindung |
| US8933241B2 (en) | 2009-04-28 | 2015-01-13 | Daiichi Sankyo Company, Limited | Method for producing olmesartan medoxomil |
| JP5697593B2 (ja) * | 2009-04-28 | 2015-04-08 | 第一三共株式会社 | 新規溶媒和物結晶 |
| WO2011007368A2 (en) * | 2009-07-14 | 2011-01-20 | Cadila Healthcare Limited | An improved process for preparation of olmesartan |
| US20120184751A1 (en) * | 2009-07-31 | 2012-07-19 | Ranbaxy Laboratories Limited | Polymorphic form of olmesartan medoxomil |
| WO2011021224A2 (en) * | 2009-08-19 | 2011-02-24 | Msn Laboratories Limited | Process for (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl4-(1-hydroxy-1-methylethyl)-2-propyl-1-[4-[2-tetrazol-5-yl)phenyl]phenyl]methylimidazole-5-carboxylate |
| CZ303188B6 (cs) * | 2010-10-29 | 2012-05-16 | Zentiva, K.S. | Zpusob výroby olmesartanu medoxomilu |
| KR101275092B1 (ko) * | 2011-05-19 | 2013-06-17 | 한미정밀화학주식회사 | 아질사르탄의 개선된 제조방법 |
| CN102351849B (zh) * | 2011-10-26 | 2013-10-02 | 齐鲁天和惠世制药有限公司 | 一种奥美沙坦酯的制备方法 |
| CN103304550B (zh) * | 2012-03-16 | 2016-01-27 | 湖南欧亚生物有限公司 | 一种奥美沙坦酯的制备方法 |
| CN103319461A (zh) * | 2013-07-02 | 2013-09-25 | 临海天宇药业有限公司 | 奥美沙坦酯中间体的制备方法以及奥美沙坦酯的合成方法 |
| CN103435602A (zh) * | 2013-07-31 | 2013-12-11 | 山东省医学科学院药物研究所 | 一种奥美沙坦酯的制备方法 |
| CN104262332A (zh) * | 2014-09-16 | 2015-01-07 | 上海信谊百路达药业有限公司 | 一种奥美沙坦酯的制备方法 |
| CN104447715B (zh) * | 2014-11-28 | 2017-06-20 | 山东新华制药股份有限公司 | 奥美沙坦酯的制备方法 |
| CN104817546B (zh) * | 2015-05-20 | 2020-02-07 | 浙江华海药业股份有限公司 | 一种奥美沙坦酯母液回收的方法 |
| CN107311990B (zh) * | 2017-07-25 | 2021-09-03 | 浙江华海致诚药业有限公司 | 一种奥美沙坦酯的制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
| ES2155827T3 (es) * | 1992-06-02 | 2001-06-01 | Sankyo Co | 4-carboxiimidazoles como antagonistas de la angiotensina ii y su uso terapeutico. |
| JP2001226372A (ja) * | 1999-12-06 | 2001-08-21 | Sumika Fine Chemicals Co Ltd | ロサルタンの結晶性または結晶化された酸付加塩およびロサルタンの精製方法 |
| ITMI20032338A1 (it) * | 2003-11-28 | 2005-05-29 | Dinamite Dipharma S P A In Forma A Bbreviata Diph | Composti feniltetrazolici. |
| CA2573800A1 (en) | 2004-09-02 | 2006-03-16 | Teva Pharmaceutical Industries Ltd. | Preparation of olmesartan medoxomil |
| EP1784398A1 (de) * | 2004-09-02 | 2007-05-16 | Teva Pharmaceutical Industries Ltd | Aufreinigung von olmesartan-medoxomil |
| GB2419592A (en) * | 2004-10-26 | 2006-05-03 | Cipla Ltd | Process for the preparation of irbesartan hydrochloride |
| US20060281800A1 (en) * | 2005-04-12 | 2006-12-14 | Glenmark Pharmaceuticals Limited | Polymorphic form of olmesartan and process for its preparation |
| EP1816131A1 (de) | 2006-02-06 | 2007-08-08 | KRKA, tovarna zdravil, d.d., Novo mesto | Verfahren zur Herstellung von Olmesartan Medoxomil |
| WO2007017135A2 (en) * | 2005-07-29 | 2007-02-15 | Krka | Process for the preparation of olmesartan medoxomil |
| WO2007052301A2 (en) | 2005-08-31 | 2007-05-10 | Alembic Limited | Process for the preparation of irbesartan |
| EP1801111B1 (de) * | 2005-12-20 | 2014-07-16 | LEK Pharmaceuticals d.d. | Polymorphe Formen von Olmesartan Medoxomil |
| EP2016073B1 (de) * | 2006-04-07 | 2011-07-27 | LEK Pharmaceuticals d.d. | Verfahren zur herstellung von reinem irbesartan |
| US8048904B2 (en) | 2006-06-19 | 2011-11-01 | Matrix Laboratories Ltd. | Process for the preparation of olmesartan medoxomil |
| AU2007306171B2 (en) * | 2006-10-09 | 2013-02-21 | Cipla Limited | Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil |
| JP5685082B2 (ja) * | 2007-08-08 | 2015-03-18 | レツク・フアーマシユーテイカルズ・デー・デー | オルメサルタンメドキソミルの調製または精製の方法 |
-
2008
- 2008-08-07 JP JP2010519468A patent/JP5685082B2/ja not_active Expired - Fee Related
- 2008-08-07 SI SI200830507T patent/SI2176253T1/sl unknown
- 2008-08-07 BR BRPI0815134-2A2A patent/BRPI0815134A2/pt not_active Application Discontinuation
- 2008-08-07 US US12/672,267 patent/US8592474B2/en not_active Expired - Fee Related
- 2008-08-07 WO PCT/EP2008/060396 patent/WO2009019303A2/en not_active Ceased
- 2008-08-07 US US12/672,264 patent/US20110224271A1/en not_active Abandoned
- 2008-08-07 CN CN200880102268A patent/CN101778843A/zh active Pending
- 2008-08-07 AT AT08786993T patent/ATE528305T1/de not_active IP Right Cessation
- 2008-08-07 CN CN200880102267.4A patent/CN101778842B/zh not_active Expired - Fee Related
- 2008-08-07 EP EP08786993A patent/EP2176253B1/de not_active Not-in-force
- 2008-08-07 EP EP08786996.2A patent/EP2173741B1/de not_active Not-in-force
- 2008-08-07 JP JP2010519469A patent/JP2010535743A/ja active Pending
- 2008-08-07 BR BRPI0815111-3A2A patent/BRPI0815111A2/pt not_active Application Discontinuation
- 2008-08-07 WO PCT/EP2008/060400 patent/WO2009019304A1/en not_active Ceased
- 2008-08-07 CA CA2707334A patent/CA2707334C/en not_active Expired - Fee Related
- 2008-08-07 CA CA2707365A patent/CA2707365A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN101778843A (zh) | 2010-07-14 |
| WO2009019303A3 (en) | 2009-04-02 |
| EP2173741A1 (de) | 2010-04-14 |
| JP5685082B2 (ja) | 2015-03-18 |
| JP2010535742A (ja) | 2010-11-25 |
| US20110224271A1 (en) | 2011-09-15 |
| CA2707334A1 (en) | 2009-02-12 |
| JP2010535743A (ja) | 2010-11-25 |
| EP2176253A2 (de) | 2010-04-21 |
| CN101778842A (zh) | 2010-07-14 |
| BRPI0815111A2 (pt) | 2015-01-27 |
| EP2176253B1 (de) | 2011-10-12 |
| US20110263666A1 (en) | 2011-10-27 |
| SI2176253T1 (sl) | 2012-02-29 |
| CA2707365A1 (en) | 2009-02-12 |
| CA2707334C (en) | 2015-11-24 |
| EP2173741B1 (de) | 2013-10-02 |
| BRPI0815134A2 (pt) | 2015-02-03 |
| CN101778842B (zh) | 2014-10-29 |
| US8592474B2 (en) | 2013-11-26 |
| WO2009019304A1 (en) | 2009-02-12 |
| WO2009019303A2 (en) | 2009-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE528305T1 (de) | Verfahren zur herstellung oder reinigung von olmesartan-medoxomil oder von olmesartan- medoxomil-hydrohalid-salz | |
| EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
| EA201001639A1 (ru) | Композиции и способы их получения и применения | |
| EA201100094A1 (ru) | Тиадиазолилоксифениламидины и их применение в качестве фунгицидов | |
| MY148258A (en) | Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments | |
| EA201200551A1 (ru) | Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения | |
| GT201200164A (es) | "nuevos compuestos de espiropiperidina" | |
| UA110983C2 (uk) | Похідна 1,2,3,4-тетрагідрохіноліну, придатна для лікування діабету | |
| EA201170753A1 (ru) | Налмефена гидрохлорид дигидрат | |
| EA201301181A1 (ru) | Триазолопиридины | |
| NZ601350A (en) | Method of treating arthritis | |
| EA201270280A1 (ru) | Соединения пиримидина в качестве ингибиторов при лечении туберкулеза | |
| EA201491286A1 (ru) | Способ лечения потери костной массы альвеолярного отростка посредством применения антител к склеростину | |
| CY1123438T1 (el) | Διαδικασια για παραγωγη και καθαρισμοανασυνδυασμενης λυσοσωμικης αλφα-μαννοσιδασης | |
| MA32943B1 (fr) | Piperidine spiro pyrrolidione et piperidinone substituees, leur preparation et leur utilisation therapeutique | |
| EA200702329A1 (ru) | Замещенные пирролпиридины, содержащие их композиции, способ получения и применение | |
| EA201190312A1 (ru) | Замещенные пиперидины | |
| WO2010098583A2 (ko) | 스타틴 화합물 또는 그 염의 신규 제조방법, 및 이에 사용되는 중간체 화합물 | |
| ATE500226T1 (de) | Aripiprazolhemifumarat und verfahren zu dessen herstellung | |
| EP3564224A3 (de) | Kristalline form von vortioxetine hydrobromid als antidepressiva-arzneimittel | |
| BRPI1014387A2 (pt) | composto, composição farmacêutica, método para tratamento ou profilaxia de uma doença, uso de um composto,e, processo para a preparação de um composto. | |
| EA200701648A1 (ru) | Замещённые пирролы и имидазолы, содержащие их композиции, способ получения и применение | |
| EA201190313A1 (ru) | Замещенные пиперидины | |
| EA200970816A1 (ru) | Новая лекарственная форма | |
| BRPI0517032A (pt) | compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades e utilização desses compostos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |